Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsClinicalTrials.gov · 2026-06-30Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic reviewJournal of Affective Disorders Reports · 2026-06-30Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-06-25Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.ACS chemical neuroscience · 2026-06-16Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-05-31Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31265 Self-reported rates of psilocybin use in North Florida, 2012 to presentUnknown journal · 2026-05-19Psilocybin-assisted Cognitive Behavioral Therapy for DepressionClinicalTrials.gov · 2026-05-18Corrigendum to: “Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape”Australian & New Zealand Journal of Psychiatry · 2026-05-17Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-13Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-05-12Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education Health and Sport · 2026-05-06Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive DisorderClinicalTrials.gov · 2026-05-031020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme DiseaseSLEEP · 2026-04-30157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium DynamicsBiological Psychiatry · 2026-04-24356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit AdaptationsResearch Square · 2026-04-22Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled TrialsOpen Access Indonesian Journal of Medical Reviews · 2026-04-20Psilocybin reshapes cortical inhibition through selective interneuron recruitmentbioRxiv · 2026-04-16A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use DisorderClinicalTrials.gov · 2026-04-06A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22A fungus among us: investigating queensland’s largest magic mushroom growing operationAustralian Journal of Forensic Sciences · 2026-03-15A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.ClinicalTrials.gov · 2026-03-02Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-02Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-17Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11Psilocybin-Induced Neuroplasticity and Sustained Antidepressant EffectsQuality in Sport · 2026-01-30PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSIONInternational Journal of Innovative Technologies in Social Science · 2026-01-27Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb PainClinicalTrials.gov · 2026-01-08COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDERGenetics and Molecular Research · 2025-12-31Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adultsNeuroscience Applied · 2025-12-31Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic peopleNeuroscience Applied · 2025-12-31Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adultsNeuroscience Applied · 2025-12-31The Effect of Magic Mushroom ( Psilocybe azurescens ) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic FactorsJournal of Neuroscience Research · 2025-12-31Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized ConditionsBiotechnology and Bioengineering · 2025-12-29The genus Psilocybe in ItalyItalian Botanist · 2025-12-21Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscapeAustralian & New Zealand Journal of Psychiatry · 2025-12-16Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challengesMycological Progress · 2025-12-07Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care PatientsJournal of Health Service Psychology · 2025-11-30Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal NeurogenesisUnknown journal · 2025-11-30Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025)Psychedelic Medicine · 2025-11-26Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyBMJ Supportive & Palliative Care · 2025-11-02Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older AdultsClinicalTrials.gov · 2025-10-20Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the BrainClinicalTrials.gov · 2025-10-20Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)ClinicalTrials.gov · 2025-10-06Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-04Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.Nature · 2025-09-30An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic TherapyClinicalTrials.gov · 2025-09-25Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on AlcoholismClinicalTrials.gov · 2025-09-23Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the USJournal of Clinical Medicine · 2025-09-18Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.Unknown journal · 2025-09-12Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelicsJournal of Psychopharmacology · 2025-08-26Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic SeizuresClinicalTrials.gov · 2025-08-20Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-19Psilocybin triggers an activity-dependent rewiring of large-scale cortical networksbioRxiv · 2025-08-05Psilocybin treatment extends cellular lifespan and improves survival of aged micenpj Aging · 2025-07-07Is there mush-room to improve the environmental sustainability of psilocybin production?Journal of CO2 Utilization · 2025-06-09Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy AdultsClinicalTrials.gov · 2025-06-09In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assaysDrug Metabolism and Pharmacokinetics · 2025-05-31Role of endogenous serotonin in psychedelic-like effects of psilocybin in miceThe International Journal of Neuropsychopharmacology · 2025-05-24Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogsJournal of Pharmacological and Toxicological Methods · 2025-04-30Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Unknown journal · 2025-04-21Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.Unknown journal · 2025-04-17Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Unknown journal · 2025-04-14Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg s Archives of Pharmacology · 2025-04-1458. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptorsNature · 2025-04-01Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de ArgentinaBoletín de la Sociedad Argentina de Botánica · 2025-03-31Psilocybin mushrooms (“Magic Mushrooms”)Organization of Teratology Information Specialists (OTIS), Brentwood (TN) · 2025-03-31Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31Pharmacokinetics of Psilocybin: A Systematic Review.Unknown journal · 2025-03-24Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-18PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-10Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-05Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)Journal of Pharmacology and Experimental Therapeutics · 2025-02-28Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case reportBMC Psychiatry · 2025-02-27Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-02-24Psychedelics and Suicide-Related Outcomes: A Systematic Review.Unknown journal · 2025-02-19Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-14International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-01-31Oregon’s Emerging Psilocybin Services Workforce: An Environmental ScanDrug and Alcohol Dependence · 2025-01-31Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit GqαFEBS Letters · 2025-01-25When death is desired: A case of MAiD & the CL psychiatrist.Palliative & supportive care · 2025-01-20A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy · 2025-01-12Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expressionbioRxiv · 2025-01-03Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2024-12-31Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent mannerNeuropharmacology · 2024-12-23The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionalsScientific Reports · 2024-11-13The Effect of Psilocybe cubensis on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2024-11-12Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug actionbioRxiv · 2024-11-02Optimized psilocybin production in tryptophan catabolism-repressed fungiMicrobial Biotechnology · 2024-10-31An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II DisorderClinicalTrials.gov · 2024-09-24Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-06-30Developing Core Consensus Measures for Assessment of Psilocybin ServicesDrug and Alcohol Dependence · 2024-06-30Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global HealthcareTrends in Medical Research · 2024-06-27Effects of psilocybin on uncertain punishment learningNeurobiology of Learning and Memory · 2024-06-21Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi studyJournal of Psychopharmacology · 2024-06-17The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybinBMC Psychiatry · 2024-04-24Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distressFrontiers in Psychiatry · 2024-04-17Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactionsDrug Metabolism and Pharmacokinetics · 2024-03-31The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderPLoS ONE · 2024-03-13NIDA: Psilocybin mushroom seizures rose significantlyAlcoholism & Drug Abuse Weekly · 2024-02-15Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative studyScientific Reports · 2024-02-04Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.Behavioral Neuroscience · 2024-01-17Effect of a single psilocybin treatment on Fos protein expression in male rat brainNeuroscience · 2024-01-03Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2023-12-31Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.Unknown journal · 2023-12-31Attitudes of European psychiatrists on psychedelics: a qualitative study.Frontiers in psychiatry · 2023-12-31Psilocybin in Bipolar II Study Provides Preliminary Data on SafetyJAMA Psychiatry · 2023-12-05Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary FindingsPsychedelic Medicine · 2023-11-30Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in ratsJournal of Psychopharmacology · 2023-10-15Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differencesScientific Reports · 2023-10-13UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBINIBRO Neuroscience Reports · 2023-09-30Manic episode following psilocybin use in a man with bipolar II disorder: a case reportFrontiers in Psychiatry · 2023-09-21Can a single dose of psilocybin improve cognitive control in functional dissociative seizures?Medical Hypotheses · 2023-09-08Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant DepressionUnknown journal · 2023-07-18Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medicationNeuropsychopharmacology · 2023-07-12Must Psilocybin Always “Assist Psychotherapy”?American Journal of Psychiatry · 2023-07-11Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant useJournal of Psychopharmacology · 2023-06-07Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autismmedRxiv · 2023-05-25Using Psilocybin Therapy for treating end of life distress trialThe Ballarat naturalist. · 2023-04-30Unblinding and demand characteristics in the treatment of depression.Journal of affective disorders · 2023-04-30118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-09The molecular basis of the antidepressant action of the magic mushroom extract, psilocinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2023-04-02Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.Unknown journal · 2023-03-21Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2022-12-31Visualizing drug actions on dendrites: psilocybin and other classic psychedelicsUnknown journal · 2022-12-31The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.Journal of psychoactive drugs · 2022-12-31On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depressionMed · 2022-12-31Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathwayFungal Genetics and Biology · 2022-12-28Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in MetabolitesApplied and Environmental Microbiology · 2022-11-28Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer.Canadian Family Physician · 2022-10-31Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Psilocybin treatment for AUD: Promise in new studyAlcoholism & Drug Abuse Weekly · 2022-10-1319.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical ConsiderationsJournal of the American Academy of Child & Adolescent Psychiatry · 2022-09-30Psilocybin as a healerConsciousness Spirituality & Transpersonal Psychology · 2022-09-11The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-08-07Evaluation of Psilocybin in Anorexia Nervosa: Safety and EfficacyClinicalTrials.gov · 2022-07-24Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.Frontiers in Psychiatry · 2022-07-06Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTMbioRxiv · 2022-07-02Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controlsVIUspace · 2022-06-29Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Scientific Reports · 2022-06-29Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.Unknown journal · 2022-06-01Magic mushroom extracts in lipid membranes.Biochimica et Biophysica Acta (BBA) - Biomembranes · 2022-05-09Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.Unknown journal · 2022-04-13Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.Psychopharmacology · 2022-03-01Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of Psychopharmacology · 2022-01-31The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03Effects of psilocybin in relative and global cerebral blood flow and behavioural correlatesNeuroscience Applied · 2021-12-31Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorderNeuroscience Applied · 2021-12-31The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-11-30Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.Scientific Reports · 2021-11-17Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.Unknown journal · 2021-10-05Psilocybin: Next to treat depression, OCD and nicotine addictionAlcoholism & Drug Abuse Weekly · 2021-09-23Testing human hair after magic mushrooms abuse by LC-MS/MS: Pitfalls and limitationsForensic Chemistry · 2021-09-19Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-08-31Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03A Case Series Describing the Tale of ‘The Magic Mushroom’; An Increasing Trend of Psychedelic Misuse Among Substance Abusers in TerengganuUnknown journal · 2021-07-26Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.Neuron · 2021-07-04The Therapeutic Potential of Psilocybin.Unknown journal · 2021-05-14O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depressionBrazilian Journal of Health Review · 2021-04-18Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Proceedings of the National Academy of Sciences · 2021-03-31Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms.Unknown journal · 2021-02-22Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivobioRxiv · 2021-02-16Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of Psychopharmacology · 2021-01-08Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2020-12-31Ethical Concerns about Psilocybin Intellectual Property.ACS Pharmacology & Translational Science · 2020-12-31A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.Unknown journal · 2020-12-20Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyEClinicalMedicine · 2020-09-23Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic MushroomPlants · 2020-08-30Psychedelics and Psychedelic-Assisted Psychotherapy.Diseño interior · 2020-02-25